Correlation Engine 2.0
Clear Search sequence regions

  • acid (1)
  • CLint (3)
  • CYP2C9 (14)
  • cyp2c9 protein human (1)
  • genotypes (4)
  • human (3)
  • ibuprofen (9)
  • P 450 (2)
  • phase (1)
  • protein human (1)
  • tris- buffer (1)
  • Sizes of these terms reflect their relevance to your search.

    Ibuprofen, a common non-steroidal anti-inflammatory drug, is used clinically for pain relief and antipyretic treatment worldwide. However, regular or long-term use of ibuprofen may lead to a series of adverse reactions, including gastrointestinal bleeding, hypertension and kidney injury. Previous studies have shown that CYP2C9 gene polymorphism plays an important role in the elimination of various drugs, which leads to the variation in drug efficacy. This study aimed to evaluate the effect of 38 CYP2C9 genotypes on ibuprofen metabolism. Thirty-eight recombinant human CYP2C9 microsomal enzymes were obtained using a frugiperda 21 insect expression system according to a previously described method. Assessment of the catalytic function of these variants was completed via a mature incubation system: 5 pmol CYP2C9*1 and 38 CYP2C9 variants recombinant human microsomes, 5 μL cytochrome B5, ibuprofen (5-1000 μM), and Tris-HCl buffer (pH 7.4). The ibuprofen metabolite contents were determined using HPLC analysis. HPLC analysis included a UV detector, Plus-C18 column, and mobile phase [50% acetonitrile and 50% water (containing 0.05% trifluoroacetic acid)]. The kinetic parameters of the CYP2C9 genotypes were obtained by Michaelis-Menten curve fitting. The intrinsic clearance (CLint) of eight variants was not significantly different from CYP2C9*1; four CYP2C9 variants (CYP2C9*38, *44, *53 and *59) showed significantly higher CLint (increase by 35%-230%) than that of the wild-type; the remaining twenty-six variants exhibited significantly reduced CLint (reduced by 30%-99%) compared to that of the wild-type. This is the first systematic evaluation of the catalytic characteristics of 38 CYP2C9 genotypes involved ibuprofen metabolism. Our results provide a corresponding supplement to studies on CYP2C9 gene polymorphisms and kinetic characteristics of different variants. We need to focus on poor metabolizers (PMs) with severely abnormal metabolic functions, because they are more susceptible to drug exposure. Copyright © 2023 Elsevier Ltd. All rights reserved.


    Ling-Jing Yuan, Xiang-Yu Li, Feng Ye, Xin-Yue Li, Qing-Qing Li, Yun-Shan Zhong, Shi-Yu Wang, Ya-Hui Wang, Guo-Xin Hu, Jian-Ping Cai, Jun-Wei Li. Enzymatic activity of 38 CYP2C9 genotypes on ibuprofen. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2023 Aug;178:113926

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 37406757

    View Full Text